Victrex plc

Equities

VCT

GB0009292243

Specialty Chemicals

Real-time Estimate Cboe Europe 08:08:58 2024-05-14 am EDT 5-day change 1st Jan Change
1,293 GBX -0.54% Intraday chart for Victrex plc -1.39% -16.17%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jefferies Keeps Victrex at Underperform, Trims PT MT
DB and Berenberg raise Diploma price target AN
Victrex expects profit to stagnate following soft opening half to year AN
BAE Systems and Mondi cut to 'neutral' AN
Stocks make steady start as investors eye US CPI AN
Transcript : Victrex plc, H1 2024 Earnings Call, May 13, 2024
Diploma upgrades annual guidance amid good momentum AN
Victrex Reports Lower Fiscal H1 Attributable Profit, Revenue MT
VICTREX PLC: ON A FULL YEAR BASIS,SEES CURRENT RUN-RATES SUP… RE
Earnings Flash (VCT.L) VICTREX Reports Fiscal H1 EPS GBX3.10 MT
VICTREX PLC: H1 24 GROUP VOLUMES DOWN 11% VS SOLID H1 23… RE
Victrex plc Reports Earnings Results for the Half Year Ended March 31, 2024 CI
UBS raises Centrica to 'buy' from 'neutral AN
Peel Hunt starts NatWest and Barclays at 'buy' AN
Victrex plc Appoints Urmi Prasad Richardson as Non-Executive Director, Effective from May 1, 2024 CI
Not a care in the world Our Logo
ANALYST RECOMMENDATIONS : Broadcom, Tesla, Walmart, Entain, Virgin Money UK Our Logo
FTSE 100 Closes Down 0.3% Dragged by Miners, Financial Stocks DJ
UK stocks fall for second week; Legal & General drags down insurance sector RE
Muted start for the LSE Our Logo
Tesco bank sold to Barclays for GBP600 million AN
Victrex sees slow start to year as quarterly revenue and volumes drop AN
Barclays buys Tesco's retail banking business AN
Victrex Logs Decline in Fiscal Q1 Group Revenue MT
Victrex plc Provides Earnings Guidance for the First Half and Full Year of Fiscal Year 2024 CI
Chart Victrex plc
More charts
Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
13 GBP
Average target price
14.93 GBP
Spread / Average Target
+14.86%
Consensus
  1. Stock Market
  2. Equities
  3. VCT Stock
  4. News Victrex plc
  5. JPMorgan Cuts Victrex PT, Reiterates Overweight Rating
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW